Risk and special populations

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
 
(14 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
{{pnc}}
 
{{pnc}}
−
 
+
{{ft|D}}
−
''which risk factors make covid worse/better/no effect''
+
''which risk factors / underlying conditions make covid worse/better/no effect;''
  
 
'''[[RSP - identifying risk factors]]'''
 
'''[[RSP - identifying risk factors]]'''
Zeile 40: Zeile 40:
 
'''[[RSP - HIV]]'''
 
'''[[RSP - HIV]]'''
  
−
'''[[RSP - DIS Children]]'''
+
'''[[Children_with_covid19_disease|RSP - DIS Children]]'''
  
 
'''[[RSP - DIS Elderly]]'''
 
'''[[RSP - DIS Elderly]]'''
Zeile 47: Zeile 47:
  
 
'''[[RSP - DIS Race]]'''
 
'''[[RSP - DIS Race]]'''
−
 
−
===007=== rsp and secondary d
 
−
 
−
{{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=007}}
 
−
{{tp|p=32490972|t=2020. COVID-19 and the eye: how much do we really know? A best evidence review.|pdf=|usr=007}}
 
−
{{tp|p=32380787|t=2020. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells.|pdf=|usr=007}}
 
−
{{tp|p=32486196|t=2020. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?|pdf=|usr=007}}
 
−
{{tp|p=32455539|t=2020. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.|pdf=|usr=007}}
 
−
{{tp|p=32423094|t=2020. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?|pdf=|usr=007}}
 
−
{{tp|p=32393136|t=2020. COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?|pdf=|usr=007}}
 
−
{{tp|p=32472662|t=2020. COVID-19 and diabetes: Is there enough evidence?|pdf=|usr=007}}
 
−
{{tp|p=32397558|t=2020. Impact of COVID-19 on the Cardiovascular System: A Review.|pdf=|usr=007}}
 
−
{{tp|p=32392741|t=2020. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.|pdf=|usr=007}}
 
−
{{tp|p=32443899|t=2020. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.|pdf=|usr=007}}
 
−
{{tp|p=32443834|t=2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.|pdf=|usr=007}}
 
−
{{tp|p=32403255|t=2020. COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.|pdf=|usr=007}}
 
−
{{tp|p=32503180|t=2020. Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.|pdf=|usr=007}}
 
−
{{tp|p=32498262|t=2020. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.|pdf=|usr=007}}
 
−
{{tp|p=32498230|t=2020. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties.|pdf=|usr=007}}
 
−
{{tp|p=32496205|t=2020. Why African Americans Are a Potential Target for COVID-19 Infection in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32449782|t=2020. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32271393|t=2020. Medical Rehabilitation in Pandemics: Towards a New Perspective.|pdf=|usr=007}}
 
−
{{tp|p=32482654|t=2020. Dr. Favalli, et al reply.|pdf=|usr=007}}
 
−
{{tp|p=32469410|t=2020. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32475878|t=2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.|pdf=|usr=007}}
 
−
{{tp|p=32475104|t=2020. Coronavirus Disease 2019 Presenting as Conjunctivitis.|pdf=|usr=007}}
 
−
{{tp|p=32314329|t=2020. ACE-2 och coronavirus - en fraga om balans och dynamik?|pdf=|usr=007}}
 
−
{{tp|p=32471831|t=2020. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".|pdf=|usr=007}}
 
−
{{tp|p=32444383|t=2020. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.|pdf=|usr=007}}
 
−
{{tp|p=32467553|t=2020. Smoking amidst the COVID-19 Pandemic - the invisible threat?|pdf=|usr=007}}
 
−
{{tp|p=32478706|t=2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?|pdf=|usr=007}}
 
−
{{tp|p=32442932|t=2020. Experiencia COVID-19 en un sanatorio privado de Buenos Aires durante el primer mes de la pandemia: 26 casos.|pdf=|usr=007}}
 
−
{{tp|p=32481381|t=2020. A case report with COVID-19 during perioperative period of lobectomy.|pdf=|usr=007}}
 
−
{{tp|p=32443345|t=2020. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report.|pdf=|usr=007}}
 
−
{{tp|p=32384516|t=2020. Novel coronavirus 2019 (COVID-19): A case report and review of treatments.|pdf=|usr=007}}
 
−
{{tp|p=32502054|t=2020. A 3-month-old child with COVID-19: A case report.|pdf=|usr=007}}
 
−
{{tp|p=32502034|t=2020. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China.|pdf=|usr=007}}
 
−
{{tp|p=32397692|t=2020. A case of Covid19 infection manifesting itself with only abdominal symptoms.|pdf=|usr=007}}
 
−
{{tp|p=32408731|t=2020. Covid-19 infection in kidney transplant recipients: endocrine and metabolic issues.|pdf=|usr=007}}
 
−
{{tp|p=32380802|t=2020. Cardiovascular system and COVID-19: perspectives from a developing country.|pdf=|usr=007}}
 
−
{{tp|p=32449614|t=2020. Gender differences in patients with COVID-19: a narrative review.|pdf=|usr=007}}
 
−
{{tp|p=32447949|t=2020. Extrapolation of mortality in COVID-19: Exploring the role of age, sex, co-morbidities and health-care related occupation.|pdf=|usr=007}}
 
−
{{tp|p=32432433|t=2020. Severity of COVID-19: The importance of being hypertensive.|pdf=|usr=007}}
 
−
{{tp|p=32425013|t=2020. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.|pdf=|usr=007}}
 
−
{{tp|p=32415003|t=2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?|pdf=|usr=007}}
 
−
{{tp|p=32457227|t=2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.|pdf=|usr=007}}
 
−
{{tp|p=32457226|t=2020. COVID-19 in MS: Initial observations from the Pacific Northwest.|pdf=|usr=007}}
 
−
{{tp|p=32482781|t=2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32461235|t=2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32444427|t=2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?|pdf=|usr=007}}
 
−
{{tp|p=32414755|t=2020. COVID-19 and MS disease-modifying therapies.|pdf=|usr=007}}
 
−
{{tp|p=32432445|t=2020. The kidney in COVID-19: protagonist or figurant?|pdf=|usr=007}}
 
−
{{tp|p=32486188|t=2020. SARS-CoV-2 Infection and the Liver.|pdf=|usr=007}}
 
−
{{tp|p=32503140|t=2020. Human T leukaemia Type 1 and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32384078|t=2020. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.|pdf=|usr=007}}
 
−
{{tp|p=32497090|t=2020. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.|pdf=|usr=007}}
 
−
{{tp|p=32420710|t=2020. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.|pdf=|usr=007}}
 
−
{{tp|p=32385979|t=2020. Diagnosis and recovery from severe acute respiratory syndrome coronavirus 2 infection is challenging in kidney patients: tests are an issue.|pdf=|usr=007}}
 
−
{{tp|p=32491298|t=2020. Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32469263|t=2020. Nierensonomorphologie bei COVID-19 mit akuter Niereninsuffizienz.|pdf=|usr=007}}
 
−
{{tp|p=32458823|t=2020. Infeccion por coronavirus Covid-19 y lactancia materna: una revision exploratoria.|pdf=|usr=007}}
 
−
{{tp|p=32390132|t=2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32491116|t=2020. A brief-review of the risk factors for covid-19 severity.|pdf=|usr=007}}
 
−
{{tp|p=32491091|t=2020. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.|pdf=|usr=007}}
 
−
{{tp|p=32491053|t=2020. Diabetes and covid-19: more than the sum of two morbidities.|pdf=|usr=007}}
 
−
{{tp|p=32507709|t=2020. Sindrome de DRESS simulando enfermedad por coronavirus 2019-NcoV.|pdf=|usr=007}}
 
−
{{tp|p=32512263|t=2020. COVID-19 in rheumatic disease patients on immunosuppressive agents.|pdf=|usr=007}}
 
−
{{tp|p=32460453|t=2020. COVID-19 in Singapore - a case series from primary care.|pdf=|usr=007}}
 
−
{{tp|p=32466735|t=2020. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32459857|t=2020. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?|pdf=|usr=007}}
 
−
{{tp|p=32506344|t=2020. Acute intestinal ischemia in a patient with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32463186|t=2020. Lungeembolisme ved covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32460390|t=2020. Covid-19 in solid organ transplant recipients: A single center experience.|pdf=|usr=007}}
 
−
{{tp|p=32429038|t=2020. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis.|pdf=|usr=007}}
 
−
{{tp|p=32395790|t=2020. COVID-19 and Cardiovascular diseases. Scoping review study.|pdf=|usr=007}}
 
−
{{tp|p=32395788|t=2020. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series.|pdf=|usr=007}}
 
−
{{tp|p=32395787|t=2020. First case of imported and confirmed COVID-19 in Tunisia.|pdf=|usr=007}}
 
−
{{tp|p=32394689|t=2020. COVID-19, Renin-angiotensin System and Hematopoiesis.|pdf=|usr=007}}
 
−
{{tp|p=32490641|t=2020. Characteristics of the initial patients hospitalized for COVID-19: a single-center report.|pdf=|usr=007}}
 
−
{{tp|p=32430957|t=2020. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review.|pdf=|usr=007}}
 
−
{{tp|p=32450787|t=2020. Liver injury in COVID-19: The current evidence.|pdf=|usr=007}}
 
−
{{tp|p=32450785|t=2020. COVID-19 and digestive health.|pdf=|usr=007}}
 
−
{{tp|p=32501145|t=2020. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).|pdf=|usr=007}}
 
−
{{tp|p=32456286|t=2020. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.|pdf=|usr=007}}
 
−
{{tp|p=32403242|t=2020. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.|pdf=|usr=007}}
 
−
{{tp|p=32463395|t=2020. The involvement of the central nervous system in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32493200|t=2020. Prevention of COVID-19 infection in the medical population: a possible help from anosmia?.|pdf=|usr=007}}
 
−
{{tp|p=32386285|t=2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.|pdf=|usr=007}}
 
−
{{tp|p=32352450|t=2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.|pdf=|usr=007}}
 
−
{{tp|p=32396143|t=2020. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study.|pdf=|usr=007}}
 
−
{{tp|p=32435811|t=2020. COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion.|pdf=|usr=007}}
 
−
{{tp|p=32355007|t=2020. The mystery of the pandemic's 'happy hypoxia'.|pdf=|usr=007}}
 
−
{{tp|p=32396963|t=2020. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?|pdf=|usr=007}}
 
−
{{tp|p=32512587|t=2020. Bleeding and Bleeding Risk in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32512586|t=2020. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.|pdf=|usr=007}}
 
−
{{tp|p=32447301|t=2020. Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.|pdf=|usr=007}}
 
−
{{tp|p=32455440|t=2020. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.|pdf=|usr=007}}
 
−
{{tp|p=32510876|t=2020. Differences in Clinical Characteristics of Covid-19 in Hispanic/Latino Population.|pdf=|usr=007}}
 
−
{{tp|p=32510771|t=2020. COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy.|pdf=|usr=007}}
 
−
{{tp|p=32510756|t=2020. Hyponatremia: A Possible Immuno-Neuroendocrine Interface with COVID-19 in a Kidney Transplant Recipient.|pdf=|usr=007}}
 
−
{{tp|p=32500942|t=2020. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.|pdf=|usr=007}}
 
−
{{tp|p=32500922|t=2020. Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected.|pdf=|usr=007}}
 
−
{{tp|p=32500666|t=2020. Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus.|pdf=|usr=007}}
 
−
{{tp|p=32492485|t=2020. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.|pdf=|usr=007}}
 
−
{{tp|p=32400381|t=2020. [De forste kliniske data fra RASi-behandlede indlagte patienter med COVID-19 kommer nu, og vi skal ikke aendre medicinering].|pdf=|usr=007}}
 
−
{{tp|p=32400371|t=2020. [Anosmia and ageusia as primary symptoms of COVID-19].|pdf=|usr=007}}
 
−
{{tp|p=32286214|t=2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].|pdf=|usr=007}}
 
−
{{tp|p=32462990|t=2020. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.|pdf=|usr=007}}
 
−
{{tp|p=32314950|t=2020. Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis.|pdf=|usr=007}}
 
−
{{tp|p=32476394|t=2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32223839|t=2020. [Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].|pdf=|usr=007}}
 
−
{{tp|p=32065520|t=2020. [First case of neonate infected with novel coronavirus pneumonia in China].|pdf=|usr=007}}
 
−
{{tp|p=32294814|t=2020. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].|pdf=|usr=007}}
 
−
{{tp|p=32447934|t=2020. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].|pdf=|usr=007}}
 
−
{{tp|p=32418377|t=2020. [Clinical analysis of kidney injury in patients with COVID-19].|pdf=|usr=007}}
 
−
{{tp|p=32496259|t=2020. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.|pdf=|usr=007}}
 
−
{{tp|p=32393678|t=2020. COVID-19: Important Issues for Pediatricians.|pdf=|usr=007}}
 
−
{{tp|p=32412915|t=2020. Managing Children with Renal Diseases during COVID-19 Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32487797|t=2020. The seXY side of COVID-19: what is behind female protection?|pdf=|usr=007}}
 
−
{{tp|p=32487793|t=2020. Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.|pdf=|usr=007}}
 
−
{{tp|p=32487789|t=2020. Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases.|pdf=|usr=007}}
 
−
{{tp|p=32468632|t=2020. Olfactory dysfunction in recovered COVID-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32449528|t=2020. Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.|pdf=|usr=007}}
 
−
{{tp|p=32470210|t=2020. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.|pdf=|usr=007}}
 
−
{{tp|p=32463562|t=2020. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?|pdf=|usr=007}}
 
−
{{tp|p=32463545|t=2020. Obesity and COVID-19: an Italian snapshot.|pdf=|usr=007}}
 
−
{{tp|p=32445512|t=2020. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.|pdf=|usr=007}}
 
−
{{tp|p=32445496|t=2020. Body Mass Index, Weight Discrimination, and Psychological, Behavioral, and Interpersonal Responses to the Coronavirus Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32428380|t=2020. Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight.|pdf=|usr=007}}
 
−
{{tp|p=32505551|t=2020. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.|pdf=|usr=007}}
 
−
{{tp|p=32507368|t=2020. SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon?|pdf=|usr=007}}
 
−
{{tp|p=32469426|t=2020. African American children are at higher risk of COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32453902|t=2020. Chilblains-like lesions and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32445583|t=2020. Erythema multiforme-like lesions in children and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32437077|t=2020. Clinical characteristics of COVID-19 in children: Are they similar to those of SARS?|pdf=|usr=007}}
 
−
{{tp|p=32501190|t=2020. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations.|pdf=|usr=007}}
 
−
{{tp|p=32461198|t=2020. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?|pdf=|usr=007}}
 
−
{{tp|p=32505834|t=2020. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?|pdf=|usr=007}}
 
−
{{tp|p=32512122|t=2020. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.|pdf=|usr=007}}
 
−
{{tp|p=32512352|t=2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.|pdf=|usr=007}}
 
−
{{tp|p=32454268|t=2020. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.|pdf=|usr=007}}
 
−
{{tp|p=32507399|t=2020. Tromboembolismo pulmonar y COVID-19: un cambio de paradigma.|pdf=|usr=007}}
 
−
{{tp|p=32463446|t=2020. Familial cluster of SARS-CoV-2 infection associated with a railway journey.|pdf=|usr=007}}
 
−
{{tp|p=32250460|t=2020. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.|pdf=|usr=007}}
 
−
{{tp|p=32502296|t=2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.|pdf=|usr=007}}
 
−
{{tp|p=32502289|t=2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.|pdf=|usr=007}}
 
−
{{tp|p=32484584|t=2020. COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.|pdf=|usr=007}}
 
−
{{tp|p=32479103|t=2020. Special report: Prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020.|pdf=|usr=007}}
 
−
{{tp|p=32467603|t=2020. Resistance of children to Covid-19. How?|pdf=|usr=007}}
 
−
{{tp|p=32463329|t=2020. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.|pdf=|usr=007}}
 
−
{{tp|p=32391998|t=2020. De eerste 29 COVID-19-patienten in de kliniek.|pdf=|usr=007}}
 
−
{{tp|p=32391997|t=2020. De eerste honderd opgenomen COVID-19-patienten in het Elisabeth-Tweesteden Ziekenhuis.|pdf=|usr=007}}
 
−
{{tp|p=32395964|t=2020. Do's-and-don'ts bij COVID-19-coagulopathie.|pdf=|usr=007}}
 
−
{{tp|p=32498065|t=2020. Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit.|pdf=|usr=007}}
 
−
{{tp|p=32468450|t=2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.|pdf=|usr=007}}
 
−
{{tp|p=32444493|t=2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.|pdf=|usr=007}}
 
−
{{tp|p=32444492|t=2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.|pdf=|usr=007}}
 
−
{{tp|p=32439822|t=2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32439821|t=2020. Generalized myoclonus in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32487714|t=2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.|pdf=|usr=007}}
 
−
{{tp|p=32482845|t=2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.|pdf=|usr=007}}
 
−
{{tp|p=32424429|t=2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.|pdf=|usr=007}}
 
−
{{tp|p=32496534|t=2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.|pdf=|usr=007}}
 
−
{{tp|p=32490520|t=2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.|pdf=|usr=007}}
 
−
{{tp|p=32237206|t=2020. Obesity and its Implications for COVID-19 Mortality.|pdf=|usr=007}}
 
−
{{tp|p=32384387|t=2020. A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32384385|t=2020. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32459701|t=2020. Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.|pdf=|usr=007}}
 
−
{{tp|p=32433453|t=2020. Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32433451|t=2020. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.|pdf=|usr=007}}
 
−
{{tp|p=32496337|t=2020. Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.|pdf=|usr=007}}
 
−
{{tp|p=32510821|t=2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.|pdf=|usr=007}}
 
−
{{tp|p=32506730|t=2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32506662|t=2020. Necrotizing periodontal disease: oral manifestation of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32419568|t=2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32453702|t=2020. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben.|pdf=|usr=007}}
 
−
{{tp|p=32423359|t=2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.|pdf=|usr=007}}
 
−
{{tp|p=32423285|t=2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.|pdf=|usr=007}}
 
−
{{tp|p=32482123|t=2020. SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit.|pdf=|usr=007}}
 
−
{{tp|p=32501861|t=2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32413201|t=2020. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.|pdf=|usr=007}}
 
−
{{tp|p=32495391|t=2020. COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation.|pdf=|usr=007}}
 
−
{{tp|p=32467457|t=2020. Severe SARS-CoV-2 Infection in Children With Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain.|pdf=|usr=007}}
 
−
{{tp|p=32467452|t=2020. ORCHIEPIDIDYMITIS IN A BOY WITH COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32404789|t=2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.|pdf=|usr=007}}
 
−
{{tp|p=32404786|t=2020. Clinical Analysis of 25 Novel Coronavirus Infections in Children.|pdf=|usr=007}}
 
−
{{tp|p=32502128|t=2020. COVID-19-Associated Myocarditis in an Adolescent.|pdf=|usr=007}}
 
−
{{tp|p=32398569|t=2020. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.|pdf=|usr=007}}
 
−
{{tp|p=32433226|t=2020. The Role of Human Coronavirus Infection in Pediatric Acute Gastroenteritis.|pdf=|usr=007}}
 
−
{{tp|p=32433225|t=2020. Acute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.|pdf=|usr=007}}
 
−
{{tp|p=32427645|t=2020. Pediatric Life-Threatening Coronavirus Disease 2019 With Myocarditis.|pdf=|usr=007}}
 
−
{{tp|p=32404791|t=2020. COVID-19 in the Pediatric Population Admitted to a Tertiary Referral Hospital in Northern Italy: Preliminary Clinical Data.|pdf=|usr=007}}
 
−
{{tp|p=32404780|t=2020. First Case of Coronavirus Disease 2019 in Childhood Leukemia in China.|pdf=|usr=007}}
 
−
{{tp|p=32384398|t=2020. COVID-19 in Neonates and Infants: Progression and Recovery.|pdf=|usr=007}}
 
−
{{tp|p=32384397|t=2020. Children Hospitalized With Severe COVID-19 in Wuhan.|pdf=|usr=007}}
 
−
{{tp|p=32384396|t=2020. Hematuria Associated With SARS-CoV-2 Infection in a Child.|pdf=|usr=007}}
 
−
{{tp|p=32492251|t=2020. Clinical manifestations of children with COVID-19: A systematic review.|pdf=|usr=007}}
 
−
{{tp|p=32483934|t=2020. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.|pdf=|usr=007}}
 
−
{{tp|p=32392382|t=2020. COVID-19: A message of hope from a young girl with severe cystic fibrosis.|pdf=|usr=007}}
 
−
{{tp|p=32439817|t=2020. Immune Thrombocytopenia (ITP) in a SARS-CoV-2 Positive Pediatric Patient.|pdf=|usr=007}}
 
−
{{tp|p=32409480|t=2020. Caring for Newborns Born to Mothers with COVID-19: More Questions than Answers.|pdf=|usr=007}}
 
−
{{tp|p=32404431|t=2020. A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in Three Febrile Infants in New York.|pdf=|usr=007}}
 
−
{{tp|p=32380898|t=2020. The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.|pdf=|usr=007}}
 
−
{{tp|p=32419564|t=2020. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32449876|t=2020. COVID-19: an unprecedented pandemia with a potential arrhythmic undertone.|pdf=|usr=007}}
 
−
{{tp|p=32434874|t=2020. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32338566|t=2020. Experiences and Insights from the Early US COVID-19 Epicenter: A Rapid Assessment Procedure Informed Clinical Ethnography Case Series.|pdf=|usr=007}}
 
−
{{tp|p=32286091|t=2020. Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?|pdf=|usr=007}}
 
−
{{tp|p=32442308|t=2020. The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.|pdf=|usr=007}}
 
−
{{tp|p=32442268|t=2020. Stroke in a young COVID -19 patient.|pdf=|usr=007}}
 
−
{{tp|p=32437314|t=2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.|pdf=|usr=007}}
 
−
{{tp|p=32437313|t=2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.|pdf=|usr=007}}
 
−
{{tp|p=32407258|t=2020. COVID-19-Associated Leukoencephalopathy.|pdf=|usr=007}}
 
−
{{tp|p=32391742|t=2020. Abdominal Imaging Findings in COVID-19: Preliminary Observations.|pdf=|usr=007}}
 
−
{{tp|p=32484418|t=2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.|pdf=|usr=007}}
 
−
{{tp|p=32374550|t=2020. Covid-19: la troublante decouverte des possibles vertus de la nicotine.|pdf=|usr=007}}
 
−
{{tp|p=32374540|t=2020. Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32374539|t=2020. Pandemie de COVID-19 : aspects cardiologiques.|pdf=|usr=007}}
 
−
{{tp|p=32462846|t=2020. COVID-19: differences de symptomatologie entre la Chine et l'Europe.|pdf=|usr=007}}
 
−
{{tp|p=32462841|t=2020. Obesite et risque de COVID-19 severe.|pdf=|usr=007}}
 
−
{{tp|p=32432429|t=2020. COVID-19: elements de connaissances concernant les enfants.|pdf=|usr=007}}
 
−
{{tp|p=32401442|t=2020. Les bloqueurs du systeme renine-angiotensine-aldosterone en temps de pandemie Covid-19 : amis ou ennemis ?|pdf=|usr=007}}
 
−
{{tp|p=32496707|t=2020. La rehabilitation: indispensable pour les survivants d'un COVID-19 severe.|pdf=|usr=007}}
 
−
{{tp|p=32348058|t=2020. Les complications cardiaques de la maladie COVID-19 sont-elles associees a une mortalite plus elevee ?|pdf=|usr=007}}
 
−
{{tp|p=32348051|t=2020. Anosmie et COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32348050|t=2020. Prise en charge des patients avec maladies digestives et hepatiques durant la pandemie COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32348048|t=2020. COVID-19 : impact pediatrique.|pdf=|usr=007}}
 
−
{{tp|p=32490966|t=2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.|pdf=|usr=007}}
 
−
{{tp|p=32469246|t=2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.|pdf=|usr=007}}
 
−
{{tp|p=32436441|t=2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.|pdf=|usr=007}}
 
−
{{tp|p=32490886|t=2020. Is there a rationale for heparin use among severe COVID-19 patients?|pdf=|usr=007}}
 
−
{{tp|p=32453917|t=2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32453685|t=2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.|pdf=|usr=007}}
 
−
{{tp|p=32441243|t=2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.|pdf=|usr=007}}
 
−
{{tp|p=32487282|t=2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.|pdf=|usr=007}}
 
−
{{tp|p=32458742|t=2020. Nurse infected with Covid-19 from a provisional dengue patient.|pdf=|usr=007}}
 
−
{{tp|p=32395943|t=2020. Pericarditis aguda secundaria a COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32392566|t=2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.|pdf=|usr=007}}
 
−
{{tp|p=32467096|t=2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32429041|t=2020. COVID-19 and Gastrointestinal Symptoms-A Case Report.|pdf=|usr=007}}
 
−
{{tp|p=32474561|t=2020. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study.|pdf=|usr=007}}
 
−
{{tp|p=32482915|t=2020. Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease.|pdf=|usr=007}}
 
−
{{tp|p=32436996|t=2020. The value of clinical parameters in predicting the severity of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32427361|t=2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.|pdf=|usr=007}}
 
−
{{tp|p=32427357|t=2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'|pdf=|usr=007}}
 
−
{{tp|p=32418237|t=2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".|pdf=|usr=007}}
 
−
{{tp|p=32418216|t=2020. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients.|pdf=|usr=007}}
 
−
{{tp|p=32503883|t=2020. Defining causality in COVID-19 and neurological disorders.|pdf=|usr=007}}
 
−
{{tp|p=32507577|t=2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.|pdf=|usr=007}}
 
−
{{tp|p=32510106|t=2020. Clinical Presentation of COVID19 in Dementia Patients.|pdf=|usr=007}}
 
−
{{tp|p=32418199|t=2020. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32470213|t=2020. All those D-dimers in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32470207|t=2020. Frequency of lupus anticoagulant in Covid-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32470198|t=2020. Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin.|pdf=|usr=007}}
 
−
{{tp|p=32470154|t=2020. Reply to 'Ibuprofen and thromboembolism in SARS-COV2'.|pdf=|usr=007}}
 
−
{{tp|p=32464707|t=2020. Macrothrombosis and stroke in patients with mild Covid-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32459046|t=2020. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32426897|t=2020. Heparin - an old drug with multiple potential targets in Covid-19 therapy.|pdf=|usr=007}}
 
−
{{tp|p=32415902|t=2020. Ibuprofen and thromboembolism in SARS-COV2.|pdf=|usr=007}}
 
−
{{tp|p=32506364|t=2020. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.|pdf=|usr=007}}
 
−
{{tp|p=32504449|t=2020. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.|pdf=|usr=007}}
 
−
{{tp|p=32492092|t=2020. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.|pdf=|usr=007}}
 
−
{{tp|p=32505466|t=2020. Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32505222|t=2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.|pdf=|usr=007}}
 
−
{{tp|p=32436600|t=2020. SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure.|pdf=|usr=007}}
 
−
{{tp|p=32505846|t=2020. The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?|pdf=|usr=007}}
 
−
{{tp|p=32512494|t=2020. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?|pdf=|usr=007}}
 
−
{{tp|p=32441063|t=2020. Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.|pdf=|usr=007}}
 
−
{{tp|p=32507110|t=2020. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.|pdf=|usr=007}}
 
−
{{tp|p=32472989|t=2020. Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?|pdf=|usr=007}}
 
−
{{tp|p=32508078|t=2020. SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development?|pdf=|usr=007}}
 
−
{{tp|p=32480326|t=2020. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32480327|t=2020. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.|pdf=|usr=007}}
 
−
{{tp|p=32460086|t=2020. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.|pdf=|usr=007}}
 
−
{{tp|p=32445201|t=2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.|pdf=|usr=007}}
 
−
{{tp|p=32510173|t=2020. Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32497344|t=2020. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature.|pdf=|usr=007}}
 
−
{{tp|p=32497334|t=2020. A missing link between SARS-CoV-2 and the eye?: ACE2 expression on the ocular surface.|pdf=|usr=007}}
 
−
{{tp|p=32497298|t=2020. Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence.|pdf=|usr=007}}
 
−
{{tp|p=32497297|t=2020. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.|pdf=|usr=007}}
 
−
{{tp|p=32497290|t=2020. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.|pdf=|usr=007}}
 
−
{{tp|p=32497288|t=2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.|pdf=|usr=007}}
 
−
{{tp|p=32508329|t=2020. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.|pdf=|usr=007}}
 
−
{{tp|p=32500549|t=2020. Clinical update on COVID-19 in pregnancy: A review article.|pdf=|usr=007}}
 
−
{{tp|p=32423324|t=2020. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.|pdf=|usr=007}}
 
−
{{tp|p=32427809|t=2020. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.|pdf=|usr=007}}
 
−
{{tp|p=32390643|t=2020. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse?|pdf=|usr=007}}
 
−
{{tp|p=32441753|t=2020. Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32441743|t=2020. A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32504532|t=2020. Coronavirus Disease 2019 in Children Cared for at Texas Children's Hospital: Initial Clinical Characteristics and Outcomes.|pdf=|usr=007}}
 
−
{{tp|p=32479632|t=2020. Characteristics of Hospitalized Pediatric COVID-19 Cases - Chicago, Illinois, March - April 2020.|pdf=|usr=007}}
 
−
{{tp|p=32401228|t=2020. Are Covid-19-positive mothers dangerous for their term and well newborn babies? Is there an answer?|pdf=|usr=007}}
 
−
{{tp|p=32404798|t=2020. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect.|pdf=|usr=007}}
 
−
{{tp|p=32495985|t=2020. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.|pdf=|usr=007}}
 
−
{{tp|p=32348627|t=2020. Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32432682|t=2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.|pdf=|usr=007}}
 
−
{{tp|p=32432681|t=2020. Nasal ACE2 Levels and COVID-19 in Children.|pdf=|usr=007}}
 
−
{{tp|p=32391864|t=2020. COVID-19 and Racial/Ethnic Disparities.|pdf=|usr=007}}
 
−
{{tp|p=32215579|t=2020. Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.|pdf=|usr=007}}
 
−
{{tp|p=32511673|t=2020. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.|pdf=|usr=007}}
 
−
{{tp|p=32250408|t=2020. Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.|pdf=|usr=007}}
 
−
{{tp|p=32293639|t=2020. COVID-19 and African Americans.|pdf=|usr=007}}
 
−
{{tp|p=32469387|t=2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.|pdf=|usr=007}}
 
−
{{tp|p=32401283|t=2020. Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US.|pdf=|usr=007}}
 
−
{{tp|p=32392288|t=2020. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.|pdf=|usr=007}}
 
−
{{tp|p=32511066|t=2020. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.|pdf=|usr=007}}
 
−
{{tp|p=32369410|t=2020. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.|pdf=|usr=007}}
 
−
{{tp|p=32394850|t=2020. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].|pdf=|usr=007}}
 
−
{{tp|p=32392591|t=2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.|pdf=|usr=007}}
 
−
{{tp|p=32471013|t=2020. Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience.|pdf=|usr=007}}
 
−
{{tp|p=32495496|t=2020. Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?|pdf=|usr=007}}
 
−
{{tp|p=32502316|t=2020. COVID-19 Infection in Early Post-Operative Period after Liver Transplantation.|pdf=|usr=007}}
 
−
{{tp|p=32485314|t=2020. Persistent SARS-CoV-2 infection and the risk for cancer.|pdf=|usr=007}}
 
−
{{tp|p=32512287|t=2020. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.|pdf=|usr=007}}
 
−
{{tp|p=32497292|t=2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32320565|t=2020. First Case of Covid-19 in the United States. Reply.|pdf=|usr=007}}
 
−
{{tp|p=32320563|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32320562|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32320561|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32320560|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32320559|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32220206|t=2020. Clinical Characteristics of Covid-19 in China. Reply.|pdf=|usr=007}}
 
−
{{tp|p=32220205|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
 
−
{{tp|p=32220204|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
 
−
{{tp|p=32220203|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
 
−
{{tp|p=32220202|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
 
−
{{tp|p=32402156|t=2020. Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.|pdf=|usr=007}}
 
−
{{tp|p=32453517|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.|pdf=|usr=007}}
 
−
{{tp|p=32453516|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32453515|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32427431|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.|pdf=|usr=007}}
 
−
{{tp|p=32427430|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32427429|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32427428|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32329974|t=2020. Mild or Moderate Covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32427903|t=2020. How to address the coronavirus's outsized toll on people of colour.|pdf=|usr=007}}
 
−
{{tp|p=32393875|t=2020. Coronavirus blood-clot mystery intensifies.|pdf=|usr=007}}
 
−
{{tp|p=32265541|t=2020. Why measles deaths are surging - and coronavirus could make it worse.|pdf=|usr=007}}
 
−
{{tp|p=32395965|t=2020. Een man met dyspneu na een COVID-19-pneumonie.|pdf=|usr=007}}
 
−
{{tp|p=32503617|t=2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.|pdf=|usr=007}}
 
−
{{tp|p=32403153|t=2020. COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen.|pdf=|usr=007}}
 
−
{{tp|p=32449179|t=2020. Mortality in Older Patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32441771|t=2020. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.|pdf=|usr=007}}
 
−
{{tp|p=32445276|t=2020. Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.|pdf=|usr=007}}
 
−
{{tp|p=32452050|t=2020. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.|pdf=|usr=007}}
 
−
{{tp|p=32459882|t=2020. Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"|pdf=|usr=007}}
 
−
{{tp|p=32455499|t=2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.|pdf=|usr=007}}
 
−
{{tp|p=32455485|t=2020. The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities.|pdf=|usr=007}}
 
−
{{tp|p=32455475|t=2020. COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.|pdf=|usr=007}}
 
−
{{tp|p=32453865|t=2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32452545|t=2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.|pdf=|usr=007}}
 
−
{{tp|p=32452542|t=2020. COVID-19 Presenting with Atypical Sweet's Syndrome.|pdf=|usr=007}}
 
−
{{tp|p=32441876|t=2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.|pdf=|usr=007}}
 
−
{{tp|p=32441830|t=2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32434277|t=2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32428303|t=2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.|pdf=|usr=007}}
 
−
{{tp|p=32428291|t=2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?|pdf=|usr=007}}
 
−
{{tp|p=32426877|t=2020. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.|pdf=|usr=007}}
 
−
{{tp|p=32426864|t=2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.|pdf=|usr=007}}
 
−
{{tp|p=32421877|t=2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?|pdf=|usr=007}}
 
−
{{tp|p=32421876|t=2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?|pdf=|usr=007}}
 
−
{{tp|p=32450607|t=2020. Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID-19) patient.|pdf=|usr=007}}
 
−
{{tp|p=32436622|t=2020. Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.|pdf=|usr=007}}
 
−
{{tp|p=32512022|t=2020. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32512021|t=2020. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge.|pdf=|usr=007}}
 
−
{{tp|p=32504736|t=2020. Tumor biomarkers predict clinical outcome of COVID-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32458565|t=2020. Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32459372|t=2020. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?|pdf=|usr=007}}
 
−
{{tp|p=32500773|t=2020. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.|pdf=|usr=007}}
 
−
{{tp|p=32470212|t=2020. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?|pdf=|usr=007}}
 
−
{{tp|p=32470211|t=2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?|pdf=|usr=007}}
 
−
{{tp|p=32470186|t=2020. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.|pdf=|usr=007}}
 
−
{{tp|p=32470174|t=2020. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.|pdf=|usr=007}}
 
−
{{tp|p=32470167|t=2020. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.|pdf=|usr=007}}
 
−
{{tp|p=32470156|t=2020. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.|pdf=|usr=007}}
 
−
{{tp|p=32462695|t=2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.|pdf=|usr=007}}
 
−
{{tp|p=32462689|t=2020. Features of enteric disease from human coronaviruses: Implications for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32462663|t=2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.|pdf=|usr=007}}
 
−
{{tp|p=32458578|t=2020. COVID-19 encephalopathy masquerading as substance withdrawal.|pdf=|usr=007}}
 
−
{{tp|p=32449972|t=2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.|pdf=|usr=007}}
 
−
{{tp|p=32449792|t=2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.|pdf=|usr=007}}
 
−
{{tp|p=32445489|t=2020. COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies.|pdf=|usr=007}}
 
−
{{tp|p=32441816|t=2020. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32441789|t=2020. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32441787|t=2020. A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32441773|t=2020. COVID-19 in a patient with HIV infection.|pdf=|usr=007}}
 
−
{{tp|p=32437017|t=2020. Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.|pdf=|usr=007}}
 
−
{{tp|p=32437016|t=2020. Obesity predisposes to the risk of higher mortality in young COVID-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32437004|t=2020. Hepatic complications of COVID-19 and its treatment.|pdf=|usr=007}}
 
−
{{tp|p=32437000|t=2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.|pdf=|usr=007}}
 
−
{{tp|p=32436998|t=2020. Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.|pdf=|usr=007}}
 
−
{{tp|p=32505530|t=2020. Co-infection with an atypical pathogen of COVID-19 in a young.|pdf=|usr=007}}
 
−
{{tp|p=32505438|t=2020. The Association Between Symptom Onset and Length of Hospital Stay in 2019 Novel Coronavirus Pneumonia Cases Without Epidemiological Trace.|pdf=|usr=007}}
 
−
{{tp|p=32505908|t=2020. Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32385130|t=2020. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32467113|t=2020. Presentation and Outcomes of Patients with ESKD and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32484893|t=2020. Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.|pdf=|usr=007}}
 
−
{{tp|p=32448041|t=2020. Covid-19 induced superimposed bacterial infection.|pdf=|usr=007}}
 
−
{{tp|p=32453074|t=2020. Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications.|pdf=|usr=007}}
 
−
{{tp|p=32510598|t=2020. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.|pdf=|usr=007}}
 
−
{{tp|p=32433344|t=2020. Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32433342|t=2020. Cardiovascular Manifestation and Treatment in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32502117|t=2020. Coronavirus disease 2019 in children: Current status.|pdf=|usr=007}}
 
−
{{tp|p=32474598|t=2020. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico.|pdf=|usr=007}}
 
−
{{tp|p=32436948|t=2020. Subacute Thyroiditis After Sars-COV-2 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32488958|t=2020. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.|pdf=|usr=007}}
 
−
{{tp|p=32488888|t=2020. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.|pdf=|usr=007}}
 
−
{{tp|p=32479133|t=2020. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.|pdf=|usr=007}}
 
−
{{tp|p=32406283|t=2020. A survey of psoriasis patients on biologics during COVID-19: a single centre experience.|pdf=|usr=007}}
 
−
{{tp|p=32363967|t=2020. A challenging case of psoriasis flare-up after COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32433220|t=2020. When life is put on hold, how do we hold on to life? - Challenges and Opportunities in Developmental and Behavioral Pediatrics during COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32394639|t=2020. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?|pdf=|usr=007}}
 
−
{{tp|p=32389027|t=2020. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32506937|t=2020. Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy.|pdf=|usr=007}}
 
−
{{tp|p=32484624|t=2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?|pdf=|usr=007}}
 
−
{{tp|p=32468512|t=2020. COVID-19 may affect the endocrine pancreas by activating Na(+)/H(+) exchanger 2 and increasing lactate levels.|pdf=|usr=007}}
 
−
{{tp|p=32474947|t=2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32510648|t=2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?|pdf=|usr=007}}
 
−
{{tp|p=32500642|t=2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".|pdf=|usr=007}}
 
−
{{tp|p=32495400|t=2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?|pdf=|usr=007}}
 
−
{{tp|p=32495368|t=2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.|pdf=|usr=007}}
 
−
{{tp|p=32491234|t=2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.|pdf=|usr=007}}
 
−
{{tp|p=32491223|t=2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.|pdf=|usr=007}}
 
−
{{tp|p=32488946|t=2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?|pdf=|usr=007}}
 
−
{{tp|p=32488910|t=2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.|pdf=|usr=007}}
 
−
{{tp|p=32506122|t=2020. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy.|pdf=|usr=007}}
 
−
{{tp|p=32490807|t=2020. Clinical Progress Note: Point-of-Care Ultrasound Applications in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32502097|t=2020. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients.|pdf=|usr=007}}
 
−
{{tp|p=32502096|t=2020. Are COVID-19 patients with hypertension at higher risk in China?|pdf=|usr=007}}
 
−
{{tp|p=32504747|t=2020. Cardiovascular complications in COVID-19: A systematic review and meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32504746|t=2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.|pdf=|usr=007}}
 
−
{{tp|p=32504741|t=2020. Does type of immunosupression influence the course of Covid-19 infection?|pdf=|usr=007}}
 
−
{{tp|p=32490559|t=2020. Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.|pdf=|usr=007}}
 
−
{{tp|p=32462792|t=2020. Sex-based dimorphism in the SARS-CoV2 virulence.|pdf=|usr=007}}
 
−
{{tp|p=32452046|t=2020. Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America.|pdf=|usr=007}}
 
−
{{tp|p=32498135|t=2020. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.|pdf=|usr=007}}
 
−
{{tp|p=32406374|t=2020. Olfactory dysfunction in the COVID-19 outbreak.|pdf=|usr=007}}
 
−
{{tp|p=32498581|t=2020. Relationship between pregnancy and coronavirus: what we know.|pdf=|usr=007}}
 
−
{{tp|p=32223477|t=2020. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns.|pdf=|usr=007}}
 
−
{{tp|p=32369209|t=2020. Clinical characteristics and outcomes of cancer patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32497287|t=2020. Anticardiolipin antibodies and COVID-19-A case report from America.|pdf=|usr=007}}
 
−
{{tp|p=32497283|t=2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.|pdf=|usr=007}}
 
−
{{tp|p=32492209|t=2020. ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''.|pdf=|usr=007}}
 
−
{{tp|p=32492199|t=2020. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea.|pdf=|usr=007}}
 
−
{{tp|p=32492193|t=2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32492188|t=2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.|pdf=|usr=007}}
 
−
{{tp|p=32484990|t=2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.|pdf=|usr=007}}
 
−
{{tp|p=32484975|t=2020. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32314808|t=2020. Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32335609|t=2020. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.|pdf=|usr=007}}
 
−
{{tp|p=32451359|t=2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.|pdf=|usr=007}}
 
−
 
−
{{tp|p=32409442|t=2020. Skin manifestations of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32409440|t=2020. The role of cardiac imaging in hospitalized COVID-19-positive patients.|pdf=|usr=007}}
 
−
{{tp|p=32409438|t=2020. Treating acute anxiety in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32409436|t=2020. Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32409434|t=2020. Renin-angiotensin system inhibitors in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32393596|t=2020. COVID-19 and pulmonary hypertension.|pdf=|usr=007}}
 
−
{{tp|p=32393593|t=2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32409435|t=2020. Coagulopathy in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32452350|t=2020. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination.|pdf=|usr=007}}
 
−
{{tp|p=32461326|t=2020. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.|pdf=|usr=007}}
 
−
{{tp|p=32461325|t=2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.|pdf=|usr=007}}
 
−
{{tp|p=32409520|t=2020. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32504100|t=2020. Ocular manifestations of coronavirus disease 2019.|pdf=|usr=007}}
 
−
{{tp|p=32437033|t=2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32437022|t=2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.|pdf=|usr=007}}
 
−
{{tp|p=32507468|t=2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.|pdf=|usr=007}}
 
−
{{tp|p=32456720|t=2020. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32460395|t=2020. Focus on kidney disease among the coronavirus disease 2019 patients: A comparative perspective between China, Italy and the United States.|pdf=|usr=007}}
 
−
{{tp|p=32447761|t=2020. Dermatological findings in COVID-19 patients: Mexican experience.|pdf=|usr=007}}
 
−
{{tp|p=32505878|t=2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.|pdf=|usr=007}}
 
−
{{tp|p=32505779|t=2020. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32505431|t=2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.|pdf=|usr=007}}
 
−
{{tp|p=32505432|t=2020. Does COVID-19 cause axonal GBS?|pdf=|usr=007}}
 
−
{{tp|p=32449224|t=2020. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.|pdf=|usr=007}}
 
−
{{tp|p=32398625|t=2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.|pdf=|usr=007}}
 
−
{{tp|p=32512349|t=2020. Clinically significant anticardiolipin antibodies associated with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32242895|t=2020. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.|pdf=|usr=007}}
 
−
{{tp|p=32498078|t=2020. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.|pdf=|usr=007}}
 
−
{{tp|p=32423251|t=2020. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS.|pdf=|usr=007}}
 
−
{{tp|p=32423249|t=2020. Physical activity/inactivity and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32397803|t=2020. Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32475157|t=2020. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).|pdf=|usr=007}}
 
−
{{tp|p=32270698|t=2020. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32233671|t=2020. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32495914|t=2020. No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive.|pdf=|usr=007}}
 
−
{{tp|p=32495913|t=2020. Severe acute dried gangrene in COVID-19 infection: a case report.|pdf=|usr=007}}
 
−
{{tp|p=32495849|t=2020. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?|pdf=|usr=007}}
 
−
{{tp|p=32441761|t=2020. COVID-19 and QT interval prolongation: more than just drug toxicity?|pdf=|usr=007}}
 
−
{{tp|p=32441223|t=2020. COVID-19 and obesity: links and risks.|pdf=|usr=007}}
 
−
{{tp|p=32511033|t=2020. COVID-19 and diabetes mellitus: implications for prognosis and clinical management.|pdf=|usr=007}}
 
−
{{tp|p=32425184|t=2020. Sindrome Takotsubo in corso di polmonite da SARS-CoV-2: una possibile complicanza cardiovascolare.|pdf=|usr=007}}
 
−
{{tp|p=32412510|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32420884|t=2020. Pathologies cardiovasculaires et Covid-19 : particularites chez les personnes agees.|pdf=|usr=007}}
 
−
{{tp|p=32434831|t=2020. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.|pdf=|usr=007}}
 
−
{{tp|p=32430348|t=2020. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms.|pdf=|usr=007}}
 
−
{{tp|p=32414813|t=2020. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.|pdf=|usr=007}}
 
−
{{tp|p=32493828|t=2020. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.|pdf=|usr=007}}
 
−
{{tp|p=32464676|t=2020. Haemostasis in Times of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32498097|t=2020. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.|pdf=|usr=007}}
 
−
{{tp|p=32431118|t=2020. [CURRENT KNOWLEDGE ON COVID-19 IN CHILDREN - CAUTIOUS OPTIMISM].|pdf=|usr=007}}
 
−
{{tp|p=32437224|t=2020. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.|pdf=|usr=007}}
 
−
{{tp|p=32461330|t=2020. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=007}}
 
−
{{tp|p=32461328|t=2020. Getting to the heart of the matter of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32451360|t=2020. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.|pdf=|usr=007}}
 
−
{{tp|p=32499236|t=2020. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?|pdf=|usr=007}}
 
−
{{tp|p=32364920|t=2020. A Case of Postoperative Covid-19 Infection After Cardiac Surgery: Lessons Learned.|pdf=|usr=007}}
 
−
{{tp|p=32473607|t=2020. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort.|pdf=|usr=007}}
 
−
{{tp|p=32415860|t=2020. Liver Biochemistries in Hospitalized Patients With COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32512611|t=2020. Endocrine Conditions and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32429774|t=2020. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.|pdf=|usr=007}}
 
−
{{tp|p=32456489|t=2020. Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?|pdf=|usr=007}}
 
−
{{tp|p=32383626|t=2020. RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study.|pdf=|usr=007}}
 
−
{{tp|p=32383624|t=2020. Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.|pdf=|usr=007}}
 
−
{{tp|p=32458694|t=2020. Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis.|pdf=|usr=007}}
 
−
{{tp|p=32493070|t=2020. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.|pdf=|usr=007}}
 
−
{{tp|p=32476472|t=2020. COVID-19: ACE2centric infective disease?|pdf=|usr=007}}
 
−
{{tp|p=32503820|t=2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.|pdf=|usr=007}}
 
−
{{tp|p=32389131|t=2020. A case of COVID-19 with an ultralong incubation period.|pdf=|usr=007}}
 
−
{{tp|p=32427018|t=2020. Several neonates reported positive for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32476551|t=2020. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?|pdf=|usr=007}}
 
−
{{tp|p=32476537|t=2020. Early experience with COVID-19 patients at academic hospital in Southwestern United States.|pdf=|usr=007}}
 
−
{{tp|p=32436835|t=2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.|pdf=|usr=007}}
 
−
{{tp|p=32418532|t=2020. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.|pdf=|usr=007}}
 
−
{{tp|p=32389117|t=2020. A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32348232|t=2020. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.|pdf=|usr=007}}
 
−
{{tp|p=32440692|t=2020. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32497397|t=2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?|pdf=|usr=007}}
 
−
{{tp|p=32496658|t=2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?|pdf=|usr=007}}
 
−
{{tp|p=32505331|t=2020. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?|pdf=|usr=007}}
 
−
{{tp|p=32506768|t=2020. Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases.|pdf=|usr=007}}
 
−
{{tp|p=32506743|t=2020. No current evidence supporting risk of using Ibuprofen in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32496583|t=2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?|pdf=|usr=007}}
 
−
{{tp|p=32496578|t=2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.|pdf=|usr=007}}
 
−
{{tp|p=32363628|t=2020. Management of older people during the COVID-19 outbreak: Recommendations from an Italian experience.|pdf=|usr=007}}
 
−
{{tp|p=32473603|t=2020. Maternal mortality from COVID-19 in Mexico.|pdf=|usr=007}}
 
−
{{tp|p=32438521|t=2020. Update on clinical outcomes of women with COVID-19 during pregnancy.|pdf=|usr=007}}
 
−
{{tp|p=32428290|t=2020. Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.|pdf=|usr=007}}
 
−
{{tp|p=32510581|t=2020. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32330289|t=2020. Be aware of misdiagnosis-Influenza A H1N1 in a pregnant patient with suspected COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32510283|t=2020. EXPRESS: COVID-19 and stroke in Iran; a case series, and effects on stroke admissions.|pdf=|usr=007}}
 
−
{{tp|p=32501751|t=2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32468166|t=2020. Acute kidney injury associated with COVID-19: another extrapulmonary manifestation.|pdf=|usr=007}}
 
−
{{tp|p=32408926|t=2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?|pdf=|usr=007}}
 
−
{{tp|p=32267662|t=2020. Pregnancy and Sars-Cov-2: A Novel Virus in a Unique Population|pdf=|usr=007}}
 
−
{{tp|p=32483000|t=2020. COVID-19 pneumonia in patients with HIV - A Case Series.|pdf=|usr=007}}
 
−
{{tp|p=32404716|t=2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.|pdf=|usr=007}}
 
−
{{tp|p=32418475|t=2020. Who are the Most At-Risk Older Adults in the COVID-19 Era? It's Not Just Those in Nursing Homes.|pdf=|usr=007}}
 
−
{{tp|p=32250655|t=2020. Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry.|pdf=|usr=007}}
 
−
{{tp|p=32497704|t=2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".|pdf=|usr=007}}
 
−
{{tp|p=32482887|t=2020. Haemorrhagic enteritis and COVID-19: causality or coincidence.|pdf=|usr=007}}
 
−
{{tp|p=32511148|t=2020. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.|pdf=|usr=007}}
 
−
{{tp|p=32364930|t=2020. Circadian rhythm sleep-wake disorders and the COVID-19 pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32364928|t=2020. Dental sleep medicine perspectives post-COVID-19: interprofessional adaptation and directions.|pdf=|usr=007}}
 
−
{{tp|p=32441248|t=2020. The impact of SARS-CoV-2 on sleep.|pdf=|usr=007}}
 
−
{{tp|p=32441246|t=2020. Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity?|pdf=|usr=007}}
 
−
{{tp|p=32356516|t=2020. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.|pdf=|usr=007}}
 
−
{{tp|p=32484776|t=2020. COVID-19 and obstructive sleep apnea.|pdf=|usr=007}}
 
−
{{tp|p=32347205|t=2020. Narcolepsy and COVID-19: sleeping on an opportunity?|pdf=|usr=007}}
 
−
{{tp|p=32449619|t=2020. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.|pdf=|usr=007}}
 
−
{{tp|p=32436736|t=2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32391713|t=2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?|pdf=|usr=007}}
 
−
 
−
{{tp|p=32464084|t=2020. The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.|pdf=|usr=007}}
 
−
{{tp|p=32415815|t=2020. Lessons Learned from COVID-19 Pandemic in Italy.|pdf=|usr=007}}
 
−
{{tp|p=32468942|t=2020. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32454503|t=2020. Stroke in COVID-19 and SARS-CoV-1.|pdf=|usr=007}}
 
−
{{tp|p=32438476|t=2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32421857|t=2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.|pdf=|usr=007}}
 
−
{{tp|p=32505730|t=2020. Uncommon presentation of COVID-19: Gastrointestinal bleeding.|pdf=|usr=007}}
 
−
{{tp|p=32508062|t=2020. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.|pdf=|usr=007}}
 
−
{{tp|p=32508037|t=2020. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32508034|t=2020. Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32508024|t=2020. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32508041|t=2020. Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.|pdf=|usr=007}}
 
−
{{tp|p=32507407|t=2020. COVID 19-An eye on the virus.|pdf=|usr=007}}
 
−
{{tp|p=32505211|t=2020. Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study.|pdf=|usr=007}}
 
−
{{tp|p=32467423|t=2020. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32458546|t=2020. Cutaneous manifestations of COVID-19: A review of the published literature.|pdf=|usr=007}}
 
−
{{tp|p=32447798|t=2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32505652|t=2020. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32505980|t=2020. Relationship between COVID-19 and obesity.|pdf=|usr=007}}
 
−
{{tp|p=32469464|t=2020. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32463179|t=2020. Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study.|pdf=|usr=007}}
 
−
{{tp|p=32463166|t=2020. Why is hyperglycemia worsening COVID-19 and its prognosis?|pdf=|usr=007}}
 
−
{{tp|p=32451317|t=2020. The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32506222|t=2020. COVID-19: Impact of and on Diabetes.|pdf=|usr=007}}
 
−
{{tp|p=32507692|t=2020. Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases.|pdf=|usr=007}}
 
−
{{tp|p=32463538|t=2020. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.|pdf=|usr=007}}
 
−
{{tp|p=32438449|t=2020. The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients.|pdf=|usr=007}}
 
−
{{tp|p=32430971|t=2020. SARS-CoV2-related myocarditis-like syndroms: Shakespeare s question: What s in a name?|pdf=|usr=007}}
 
−
{{tp|p=32507518|t=2020. Does active smoking worsen Covid-19?|pdf=|usr=007}}
 
−
{{tp|p=32460417|t=2020. COVID-19 - neurologists stay aware!|pdf=|usr=007}}
 
−
{{tp|p=32460415|t=2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?|pdf=|usr=007}}
 
−
{{tp|p=32449247|t=2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.|pdf=|usr=007}}
 
−
{{tp|p=32449248|t=2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.|pdf=|usr=007}}
 
−
{{tp|p=32443166|t=2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).|pdf=|usr=007}}
 
−
{{tp|p=32416028|t=2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.|pdf=|usr=007}}
 
−
{{tp|p=32505514|t=2020. COVID-19 infection during the third trimester of pregnancy: Current clinical dilemmas.|pdf=|usr=007}}
 
−
{{tp|p=32504135|t=2020. Point-of-care lung ultrasound in three neonates with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32339038|t=2020. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.|pdf=|usr=007}}
 
−
{{tp|p=32500721|t=2020. Approach to Acute Cardiovascular Complications in COVID-19 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32482087|t=2020. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.|pdf=|usr=007}}
 
−
{{tp|p=32508261|t=2020. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32469253|t=2020. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study.|pdf=|usr=007}}
 
−
{{tp|p=32421381|t=2020. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.|pdf=|usr=007}}
 
−
{{tp|p=32412320|t=2020. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan.|pdf=|usr=007}}
 
−
{{tp|p=32507123|t=2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32386189|t=2020. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32386188|t=2020. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32432563|t=2020. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation.|pdf=|usr=007}}
 
−
{{tp|p=32406381|t=2020. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.|pdf=|usr=007}}
 
−
{{tp|p=32423908|t=2020. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.|pdf=|usr=007}}
 
−
{{tp|p=32390405|t=2020. COVID-19 Viral Load of an Infected Family in China.|pdf=|usr=007}}
 
−
{{tp|p=32423903|t=2020. Thrombotic risk in COVID-19: a case series and case-control study.|pdf=|usr=007}}
 
−
{{tp|p=32414711|t=2020. The renin-angiotensin system - a therapeutic target in COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32503799|t=2020. Abrupt deterioration and pulmonary embolism in COVID-19: a case report.|pdf=|usr=007}}
 
−
{{tp|p=32452757|t=2020. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?|pdf=|usr=007}}
 
−
{{tp|p=32512408|t=2020. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32462940|t=2020. Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge.|pdf=|usr=007}}
 
−
{{tp|p=32468411|t=2020. COVID-19 and Asthma: Reflection During the Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32507883|t=2020. Covid-19: the renin-angiotensin system imbalance hypothesis.|pdf=|usr=007}}
 
−
{{tp|p=32459672|t=2020. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.|pdf=|usr=007}}
 
−
{{tp|p=32463005|t=2020. The COVID-19 Pandemic: A Challenge for the Cardiovascular Health.|pdf=|usr=007}}
 
−
{{tp|p=32442082|t=2020. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.|pdf=|usr=007}}
 
−
{{tp|p=32448405|t=2020. Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020.|pdf=|usr=007}}
 
−
{{tp|p=32475056|t=2020. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment.|pdf=|usr=007}}
 
−
{{tp|p=32475035|t=2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.|pdf=|usr=007}}
 
−
{{tp|p=32474988|t=2020. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.|pdf=|usr=007}}
 
−
{{tp|p=32424886|t=2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.|pdf=|usr=007}}
 
−
{{tp|p=32418320|t=2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.|pdf=|usr=007}}
 
−
{{tp|p=32406078|t=2020. COVID-19 in an elderly patient treated with secukinumab.|pdf=|usr=007}}
 
−
{{tp|p=32506813|t=2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.|pdf=|usr=007}}
 
−
{{tp|p=32500647|t=2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.|pdf=|usr=007}}
 
−
{{tp|p=32500589|t=2020. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.|pdf=|usr=007}}
 
−
{{tp|p=32500580|t=2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32478942|t=2020. Covid-19 infection in psoriasis patients treated with cyclosporin.|pdf=|usr=007}}
 
−
{{tp|p=32430456|t=2020. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?|pdf=|usr=007}}
 
−
{{tp|p=32409505|t=2020. COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.|pdf=|usr=007}}
 
−
{{tp|p=32409504|t=2020. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.|pdf=|usr=007}}
 
−
{{tp|p=32409502|t=2020. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.|pdf=|usr=007}}
 
−
{{tp|p=32409499|t=2020. Obesity Is a Risk Factor for Greater COVID-19 Severity.|pdf=|usr=007}}
 
−
{{tp|p=32409498|t=2020. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.|pdf=|usr=007}}
 
−
{{tp|p=32496012|t=2020. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32482296|t=2020. COVID-19: Perspectives from people with diabetes.|pdf=|usr=007}}
 
−
{{tp|p=32478675|t=2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32423922|t=2020. More advice on the use of ibuprofen for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32468357|t=2020. An unresponsive COVID-19 patient.|pdf=|usr=007}}
 
−
{{tp|p=32464652|t=2020. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?|pdf=|usr=007}}
 
−
{{tp|p=32464641|t=2020. Does epicardial fat contribute to COVID-19 myocardial inflammation?|pdf=|usr=007}}
 
−
{{tp|p=32459851|t=2020. Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.|pdf=|usr=007}}
 
−
{{tp|p=32441750|t=2020. Angioedema in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32432700|t=2020. Return to sports after COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32282026|t=2020. Call to action for the cardiovascular side of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32498076|t=2020. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.|pdf=|usr=007}}
 
−
{{tp|p=32464642|t=2020. Myocardial injury in severe COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32449762|t=2020. Acute coronary syndromes during COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32432723|t=2020. Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.|pdf=|usr=007}}
 
−
{{tp|p=32432704|t=2020. Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.|pdf=|usr=007}}
 
−
{{tp|p=32462177|t=2020. Myocarditis detected after COVID-19 recovery.|pdf=|usr=007}}
 
−
{{tp|p=32464637|t=2020. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.|pdf=|usr=007}}
 
−
{{tp|p=32501480|t=2020. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.|pdf=|usr=007}}
 
−
{{tp|p=32501477|t=2020. Antihypertensive drugs in COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32511752|t=2020. COVID-19 and End Stage Renal Disease.|pdf=|usr=007}}
 
−
{{tp|p=32511751|t=2020. SARS-CoV-2: what is known and what there is to know. Focus on coagulation and lipids.|pdf=|usr=007}}
 
−
{{tp|p=32469251|t=2020. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?|pdf=|usr=007}}
 
−
{{tp|p=32453009|t=2020. Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32282549|t=2020. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.|pdf=|usr=007}}
 
−
{{tp|p=32485082|t=2020. ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust.|pdf=|usr=007}}
 
−
{{tp|p=32503088|t=2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.|pdf=|usr=007}}
 
−
{{tp|p=32503084|t=2020. Miller-Fisher syndrome after SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32503080|t=2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.|pdf=|usr=007}}
 
−
{{tp|p=32492256|t=2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.|pdf=|usr=007}}
 
−
{{tp|p=32478936|t=2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.|pdf=|usr=007}}
 
−
{{tp|p=32450718|t=2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?|pdf=|usr=007}}
 
−
{{tp|p=32396903|t=2020. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?|pdf=|usr=007}}
 
−
{{tp|p=32238235|t=2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.|pdf=|usr=007}}
 
−
{{tp|p=32433817|t=2020. Prolonged Confusional state as first manifestation of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32498096|t=2020. Intramural Hematoma as Unexpected Complication of COVID-19 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32470281|t=2020. La bronquiolitis en el ano del COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32505489|t=2020. ROLE OF REHABILITATION DEPARTMENT FOR ADULT COVID-19 PATIENTS: THE EXPERIENCE OF THE SAN RAFFAELE HOSPITAL OF MILAN.|pdf=|usr=007}}
 
−
{{tp|p=32401850|t=2020. Coronavirus e o Coracao | Um Relato de Caso sobre a Evolucao da COVID-19 Associado a Evolucao Cardiologica.|pdf=|usr=007}}
 
−
{{tp|p=32401847|t=2020. O Coracao e a COVID-19: O que o Cardiologista Precisa Saber.|pdf=|usr=007}}
 
−
{{tp|p=32401844|t=2020. COVID-19: Dados Atualizados e sua Relacao Com o Sistema Cardiovascular.|pdf=|usr=007}}
 
−
{{tp|p=32491075|t=2020. Implicacoes Cardiovasculares em Pacientes Infectados com Covid-19 e a Importancia do Isolamento Social para Reduzir a Disseminacao da Doenca.|pdf=|usr=007}}
 
−
{{tp|p=32491074|t=2020. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapeutica.|pdf=|usr=007}}
 
−
{{tp|p=32491073|t=2020. O Efeito da Doenca de Coronavirus 2019 nas Doencas Cardiovasculares.|pdf=|usr=007}}
 
−
{{tp|p=32386125|t=2020. Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.|pdf=|usr=007}}
 
−
{{tp|p=32458534|t=2020. Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab.|pdf=|usr=007}}
 
−
{{tp|p=32472827|t=2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.|pdf=|usr=007}}
 
−
{{tp|p=32512532|t=2020. Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger.|pdf=|usr=007}}
 
−
{{tp|p=32453688|t=2020. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.|pdf=|usr=007}}
 
−
{{tp|p=32471884|t=2020. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.|pdf=|usr=007}}
 
−
{{tp|p=32467124|t=2020. 80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32503812|t=2020. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.|pdf=|usr=007}}
 
−
{{tp|p=32460349|t=2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32469077|t=2020. Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience.|pdf=|usr=007}}
 
−
{{tp|p=32460350|t=2020. Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32453889|t=2020. Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32453877|t=2020. Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32453861|t=2020. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32438482|t=2020. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.|pdf=|usr=007}}
 
−
{{tp|p=32438458|t=2020. Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32420629|t=2020. Evans syndrome in a patient with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32420615|t=2020. Dynamic relationship between D-dimer and COVID-19 severity.|pdf=|usr=007}}
 
−
{{tp|p=32420614|t=2020. First COVID-19 maternal mortality in the UK associated with thrombotic complications.|pdf=|usr=007}}
 
−
{{tp|p=32420612|t=2020. COVID-19-associated immune thrombocytopenia.|pdf=|usr=007}}
 
−
{{tp|p=32420611|t=2020. More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.|pdf=|usr=007}}
 
−
{{tp|p=32420609|t=2020. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.|pdf=|usr=007}}
 
−
{{tp|p=32420608|t=2020. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.|pdf=|usr=007}}
 
−
{{tp|p=32452530|t=2020. Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32408910|t=2020. Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement.|pdf=|usr=007}}
 
−
{{tp|p=32470162|t=2020. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32427416|t=2020. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.|pdf=|usr=007}}
 
−
{{tp|p=32506683|t=2020. D-dimer triage for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32412848|t=2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.|pdf=|usr=007}}
 
−
{{tp|p=32492436|t=2020. Covid-19 may be exacerbated by right-to-left interatrial shunt.|pdf=|usr=007}}
 
−
{{tp|p=32444450|t=2020. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.|pdf=|usr=007}}
 
−
{{tp|p=32422078|t=2020. Effects of SARS-CoV-2 infection on pregnant women and their infants: A retrospective study in Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32338533|t=2020. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.|pdf=|usr=007}}
 
−
{{tp|p=32320546|t=2020. Criterios para la gestion de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluna en el contexto de pandemia.|pdf=|usr=007}}
 
−
{{tp|p=32506699|t=2020. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?|pdf=|usr=007}}
 
−
{{tp|p=32475091|t=2020. Cardiovascular conditions and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32427288|t=2020. ACE2 Receptor Expression in Testes: Implications in COVID-19 Pathogenesis.|pdf=|usr=007}}
 
−
{{tp|p=32462179|t=2020. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.|pdf=|usr=007}}
 
−
{{tp|p=32492712|t=2020. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32376670|t=2020. Covid-19: the challenge of patient rehabilitation after intensive care.|pdf=|usr=007}}
 
−
{{tp|p=32366505|t=2020. Covid-19 and pregnancy.|pdf=|usr=007}}
 
−
{{tp|p=32439704|t=2020. Covid-19 and thrombosis: what do we know about the risks and treatment?|pdf=|usr=007}}
 
−
{{tp|p=32434891|t=2020. Covid-19 and cardiovascular disease.|pdf=|usr=007}}
 
−
{{tp|p=32398229|t=2020. Covid-19: Low skilled men have highest death rate of working age adults.|pdf=|usr=007}}
 
−
{{tp|p=32393504|t=2020. Covid-19: Known risk factors fail to explain the increased risk of death among people from ethnic minorities.|pdf=|usr=007}}
 
−
{{tp|p=32357954|t=2020. Covid-19 is no worse in immunocompromised children, says NICE.|pdf=|usr=007}}
 
−
{{tp|p=32217618|t=2020. Covid-19: risk factors for severe disease and death.|pdf=|usr=007}}
 
−
{{tp|p=32213482|t=2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?|pdf=|usr=007}}
 
−
{{tp|p=32209544|t=2020. Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.|pdf=|usr=007}}
 
−
{{tp|p=32327432|t=2020. Covid-19: Doctors should be alert for signs of myocardial injury, says NICE.|pdf=|usr=007}}
 
−
{{tp|p=32291260|t=2020. Covid-19: Nine in 10 pregnant women with infection when admitted for delivery are asymptomatic, small study finds.|pdf=|usr=007}}
 
−
{{tp|p=32303575|t=2020. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications.|pdf=|usr=007}}
 
−
{{tp|p=32467101|t=2020. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.|pdf=|usr=007}}
 
−
{{tp|p=32378464|t=2020. Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32479680|t=2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.|pdf=|usr=007}}
 
−
{{tp|p=32497248|t=2020. Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus.|pdf=|usr=007}}
 
−
{{tp|p=32484907|t=2020. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32484906|t=2020. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.|pdf=|usr=007}}
 
−
{{tp|p=32484901|t=2020. Re The source of elevated plasma D-dimer levels in COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32479664|t=2020. A Case Series of MGUS and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32468862|t=2020. Licking the lungs, biting the brain: malignant MCA infarct in a patient with COVID 19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32475821|t=2020. The Stanford Hall consensus statement for post-COVID-19 rehabilitation.|pdf=|usr=007}}
 
−
{{tp|p=32492174|t=2020. First case of acute pancreatitis related to SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32311273|t=2020. Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience.|pdf=|usr=007}}
 
−
{{tp|p=32468972|t=2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32493536|t=2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.|pdf=|usr=007}}
 
−
{{tp|p=32493522|t=2020. The impact of the Covid-19 Pandemic on Stroke Volume.|pdf=|usr=007}}
 
−
{{tp|p=32484130|t=2020. COVID-19 associated central nervous system vasculopathy.|pdf=|usr=007}}
 
−
{{tp|p=32471876|t=2020. Registries Offer Insights on COVID-19-Cancer Connection.|pdf=|usr=007}}
 
−
{{tp|p=32398243|t=2020. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers.|pdf=|usr=007}}
 
−
{{tp|p=32427636|t=2020. ACE Inhibitors and ARBs in Patients with COVID-19: Friend or Foe?|pdf=|usr=007}}
 
−
{{tp|p=32496364|t=2020. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?|pdf=|usr=007}}
 
−
{{tp|p=32427637|t=2020. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.|pdf=|usr=007}}
 
−
{{tp|p=32494800|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=007}}
 
−
{{tp|p=32490506|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=007}}
 
−
{{tp|p=32473085|t=2020. SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.|pdf=|usr=007}}
 
−
{{tp|p=32473051|t=2020. Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.|pdf=|usr=007}}
 
−
{{tp|p=32403983|t=2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.|pdf=|usr=007}}
 
−
{{tp|p=32209890|t=2020. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.|pdf=|usr=007}}
 
−
{{tp|p=32432519|t=2020. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?|pdf=|usr=007}}
 
−
{{tp|p=32511019|t=2020. COVID-19 infection at nighttime.|pdf=|usr=007}}
 
−
{{tp|p=32498625|t=2020. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities.|pdf=|usr=007}}
 
−
{{tp|p=32434385|t=2020. Cardiac Arrhythmias in COVID-19 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32397816|t=2020. Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging.|pdf=|usr=007}}
 
−
{{tp|p=32474587|t=2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.|pdf=|usr=007}}
 
−
{{tp|p=32473009|t=2020. Age-dependent gender differences of COVID-19 in mainland China: comparative study.|pdf=|usr=007}}
 
−
{{tp|p=32472683|t=2020. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32472676|t=2020. Predictors for Severe COVID-19 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32472138|t=2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32463454|t=2020. Alterations in smell or taste - Classic COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32459833|t=2020. Hospitalized patients with COVID-19 and HIV: a case series.|pdf=|usr=007}}
 
−
{{tp|p=32444880|t=2020. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.|pdf=|usr=007}}
 
−
{{tp|p=32442294|t=2020. Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32442285|t=2020. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.|pdf=|usr=007}}
 
−
{{tp|p=32442265|t=2020. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.|pdf=|usr=007}}
 
−
{{tp|p=32442259|t=2020. Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?|pdf=|usr=007}}
 
−
{{tp|p=32433729|t=2020. Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children.|pdf=|usr=007}}
 
−
{{tp|p=32211755|t=2020. Epidemiological and Clinical Predictors of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32502247|t=2020. Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?|pdf=|usr=007}}
 
−
{{tp|p=32444393|t=2020. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.|pdf=|usr=007}}
 
−
 
−
{{tp|p=32441332|t=2020. Clinical course of coronavirus disease-2019 in pregnancy.|pdf=|usr=007}}
 
−
{{tp|p=32436625|t=2020. Low risk of SARS-CoV-2 transmission through the ocular surface.|pdf=|usr=007}}
 
−
{{tp|p=32421258|t=2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.|pdf=|usr=007}}
 
−
{{tp|p=32470948|t=2020. Why does COVID-19 disproportionately affect older people?|pdf=|usr=007}}
 
−
{{tp|p=32499448|t=2020. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.|pdf=|usr=007}}
 
−
{{tp|p=32507570|t=2020. Acute myocarditis associated with COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32496339|t=2020. Lipase Elevation in Patients With COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32483005|t=2020. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.|pdf=|usr=007}}
 
−
{{tp|p=32445584|t=2020. Immune thrombocytopenia due to COVID-19 during pregnancy.|pdf=|usr=007}}
 
−
{{tp|p=32512038|t=2020. IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.|pdf=|usr=007}}
 
−
{{tp|p=32459524|t=2020. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.|pdf=|usr=007}}
 
−
{{tp|p=32421367|t=2020. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.|pdf=|usr=007}}
 
−
{{tp|p=32396497|t=2020. COVID-19-associated SIADH: a clue in the times of pandemic!|pdf=|usr=007}}
 
−
{{tp|p=32491949|t=2020. Understanding the age divide in COVID-19: Why are children overwhelmingly spared?|pdf=|usr=007}}
 
−
{{tp|p=32432918|t=2020. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.|pdf=|usr=007}}
 
−
{{tp|p=32401670|t=2020. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?|pdf=|usr=007}}
 
−
{{tp|p=32412303|t=2020. Is the kidney a target of SARS-CoV-2?|pdf=|usr=007}}
 
−
{{tp|p=32436646|t=2020. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience.|pdf=|usr=007}}
 
−
{{tp|p=32503857|t=2020. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.|pdf=|usr=007}}
 
−
{{tp|p=32469504|t=2020. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32491829|t=2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.|pdf=|usr=007}}
 
−
{{tp|p=32420961|t=2020. Report of a series of healthy term newborns from convalescent mothers with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32420955|t=2020. Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease (2019-nCoV) in a central area of Calabria region.|pdf=|usr=007}}
 
−
{{tp|p=32420954|t=2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.|pdf=|usr=007}}
 
−
{{tp|p=32420950|t=2020. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.|pdf=|usr=007}}
 
−
{{tp|p=32420949|t=2020. Rare Anaemias, Sickle-Cell Disease and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32420948|t=2020. SARS-CoV-2 infection in children in Parma.|pdf=|usr=007}}
 
−
{{tp|p=32420942|t=2020. COVID19: potential cardiovascular issues in pediatric patients.|pdf=|usr=007}}
 
−
{{tp|p=32420941|t=2020. Novel coronavirus infection and children.|pdf=|usr=007}}
 
−
{{tp|p=32420939|t=2020. Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.|pdf=|usr=007}}
 
−
{{tp|p=32420934|t=2020. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.|pdf=|usr=007}}
 
−
{{tp|p=32420930|t=2020. Primum non nocere. The SARS-CoV-2 pandemic course in oldest.|pdf=|usr=007}}
 
−
{{tp|p=32420925|t=2020. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?|pdf=|usr=007}}
 
−
{{tp|p=32474914|t=2020. Anxiety and depression levels among pregnant women with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32473022|t=2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.|pdf=|usr=007}}
 
−
{{tp|p=32483943|t=2020. Episcleritis as an ocular manifestation in a patient with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32470131|t=2020. The COVID-19 Rehabilitation Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32449420|t=2020. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG.|pdf=|usr=007}}
 
−
{{tp|p=32508193|t=2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.|pdf=|usr=007}}
 
−
{{tp|p=32501851|t=2020. SARS-CoV-2 infection in a highly experienced person living with HIV.|pdf=|usr=007}}
 
−
{{tp|p=32501850|t=2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.|pdf=|usr=007}}
 
−
{{tp|p=32469614|t=2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.|pdf=|usr=007}}
 
−
{{tp|p=32407127|t=2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=007}}
 
−
{{tp|p=32467191|t=2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.|pdf=|usr=007}}
 
−
{{tp|p=32467190|t=2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.|pdf=|usr=007}}
 
−
{{tp|p=32467189|t=2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.|pdf=|usr=007}}
 
−
{{tp|p=32439646|t=2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.|pdf=|usr=007}}
 
−
{{tp|p=32409316|t=2020. Cerebrovascular Disease in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32354715|t=2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32383969|t=2020. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.|pdf=|usr=007}}
 
−
{{tp|p=32478611|t=2020. Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia".|pdf=|usr=007}}
 
−
{{tp|p=32470238|t=2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32511678|t=2020. Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.|pdf=|usr=007}}
 
−
{{tp|p=32380565|t=2020. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?|pdf=|usr=007}}
 
−
{{tp|p=32438425|t=2020. COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.|pdf=|usr=007}}
 
−
{{tp|p=32428964|t=2020. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32403141|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.|pdf=|usr=007}}
 
−
{{tp|p=32503058|t=2020. Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?|pdf=|usr=007}}
 
−
{{tp|p=32467494|t=2020. In response to: Simpson R and Robinson L: Rehabilitation following critical illness in people with COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32467490|t=2020. The place of early rehabilitation in ICU for Covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32396381|t=2020. COVID-19 Associated Pulmonary Aspergillosis.|pdf=|usr=007}}
 
−
{{tp|p=32510975|t=2020. Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?|pdf=|usr=007}}
 
−
{{tp|p=32471004|t=2020. Early COVID-19 infection after lung transplantation.|pdf=|usr=007}}
 
−
{{tp|p=32471001|t=2020. COVID-19 in elderly kidney transplant recipients.|pdf=|usr=007}}
 
−
{{tp|p=32492753|t=2020. Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation.|pdf=|usr=007}}
 
−
{{tp|p=32483909|t=2020. Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient.|pdf=|usr=007}}
 
−
{{tp|p=32476258|t=2020. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States.|pdf=|usr=007}}
 
−
{{tp|p=32431287|t=2020. Critical Care Management of Patients with COVID-19: Early Experience in Thailand.|pdf=|usr=007}}
 
−
{{tp|p=32419694|t=2020. Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness-A Tropical World Threat.|pdf=|usr=007}}
 
−
{{tp|p=32500854|t=2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32503849|t=2020. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.|pdf=|usr=007}}
 
−
{{tp|p=32503848|t=2020. Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.|pdf=|usr=007}}
 
−
{{tp|p=32205336|t=2020. Are my patients with rheumatic diseases at higher risk of COVID-19?|pdf=|usr=007}}
 
−
{{tp|p=32354774|t=2020. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.|pdf=|usr=007}}
 
−
{{tp|p=32354773|t=2020. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.|pdf=|usr=007}}
 
−
{{tp|p=32321723|t=2020. What is the true incidence of COVID-19 in patients with rheumatic diseases?|pdf=|usr=007}}
 
−
 
−
'''others'''
 
−
{{tp|p=32276139|t=2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster |pdf=|usr=}}
 
−
{{tp|p=32276140|t=2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients |pdf=|usr=}}
 
−
{{tp|p=32283499|t=2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers |pdf=|usr=}}
 
−
{{tp|p=32228738|t=ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease |pdf=|usr=}}
 
−
{{tp|p=32256706|t=2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?|pdf=|usr=}}
 
−
{{tp|p=32134381|t=2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China |pdf=|usr=}}
 
−
{{tp|p=C7141546|t=ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
 
−
{{tp|p=32269089|t=2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 |pdf=|usr=}}
 
−
{{tp|p=32307025|t=ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?|pdf=|usr=}}
 
−
{{tp|p=32355869|t=ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than  males?|pdf=|usr=}}
 
−
{{tp|p=32253068|t=2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |pdf=|usr=}}
 
−
{{tp|p=32335513|t=2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis |pdf=|usr=}}
 
−
{{tp|p=32334645|t=2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection |pdf=|usr=}}
 
−
{{tp|p=32332856|t=ä. COVID-19 in persons with haematological cancers |pdf=|usr=}}
 
−
{{tp|p=32303807|t=ä. Electronic cigarette and vaping should be discouraged during the new coronavirus  SARS-CoV-2 pandemic |pdf=|usr=}}
 
−
{{tp|p=32339776|t=2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease |pdf=|usr=}}
 
−
{{tp|p=32320740|t=ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019 |pdf=|usr=}}
 
−
{{tp|p=32302077|t=ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China |pdf=|usr=}}
 
−
{{tp|p=32289171|t=ä. Cardiac drugs and outcome in COVID-19: Reply |pdf=|usr=}}
 
−
{{tp|p=32289168|t=ä. Cardiac drugs and outcome in COVID - 19 |pdf=|usr=}}
 
−
{{tp|p=32379903|t=2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected  with SARS-CoV-2 |pdf=|usr=}}
 
−
{{tp|p=32369615|t=2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |pdf=|usr=}}
 
−
{{tp|p=32266501|t=ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 |pdf=|usr=}}
 
−
{{tp|p=32352633|t=2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients |pdf=|usr=}}
 
−
{{tp|p=32339025|t=2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best  Friend |pdf=|usr=}}
 
−
*[https://www.boston25news.com/news/health/high-blood-pressure-drugs-cleared-covid/UC5LTCKKKVDETBWKJDZ2P776XY/ ACEI/AT1RA not risky ?]
 
−
 
−
{{tp|p=32320270|t=2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms |pdf=|usr=}}
 
−
{{tp|p=32259878|t=ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?|pdf=|usr=}}
 
−
{{tp|p=32369240|t=2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind |pdf=|usr=}}
 
−
{{tp|p=32367558|t=2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?|pdf=|usr=}}
 
−
 
−
{{tp|p=32310015|t=2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature |pdf=|usr=}}
 
−
 
−
{{tp|p=32347572|t=2020. Outcome of Parkinson s Disease Patients Affected by COVID-19 |pdf=|usr=}}
 
−
 
−
{{tp|p=32360210|t=2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection |pdf=|usr=}}
 
−
{{tp|p=32386796|t=ä. Children are at risk from COVID-19 |pdf=|usr=}}
 
−
{{tp|p=32324968|t=2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?|pdf=|usr=}}
 
−
{{tp|p=32413819|t=2020. Vitamin D concentrations and COVID-19 infection in UK Biobank |pdf=|usr=}}
 
−
{{tp|p=32291196|t=2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
 

Aktuelle Version vom 12. September 2020, 17:25 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

 D further streaming-in related content is here

which risk factors / underlying conditions make covid worse/better/no effect;

RSP - identifying risk factors

which characteristics has covid in a diseased patient with underlying disorder/state

RSP - Pregnancy, Neonatology

RSP - Liver disease

RSP - Diabetes, Obesity

RSP - Kidney disease

RSP - any transplantation

RSP - any on biologicals

RSP - On RAS drugs

RSP - On NSAIDs

RSP - Smoking

RSP - Pulmonary disease

RSP - Cystic fibrosis

RSP - Cardiovascular disease

RSP - Cancer solid

RSP - Cancer hematology

RSP - Hematology other

RSP - HIV

RSP - DIS Children

RSP - DIS Elderly

RSP - DIS Male

RSP - DIS Race

Von „http://coviki.org/cov/index.php?title=Risk_and_special_populations&oldid=5661“
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis